August 22nd 2025
Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.
Timely surveillance reported in under half of HPV-positive patients
January 20th 2025A recent study highlights gaps in cervical cancer screening compliance, with fewer than 50% of human papillomavirus-positive, negative for intraepithelial lesion or malignancy patients receiving recommended follow-up testing within the guideline time frame.
Read More
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities
December 17th 2024A quality improvement project highlights the benefits of starting human papillomavirus vaccination at age 9 years to increase uptake and reduce disparities in cancer prevention across pediatric populations.
Watch
Reduced cost-effectiveness reported from HPV vaccination in mid-adults
November 27th 2024A recent study highlights the reduced cost-effectiveness of expanding human papillomavirus vaccination to adults aged 27 to 45 years compared to younger groups, though targeted strategies for high-risk subgroups indicate benefits.
Read More
Minimal recovery in HPV vaccination reported in Japan despite recommendations
July 17th 2024HPV vaccination coverage in Japan remains critically low despite the resumption of proactive recommendations by the Ministry of Health, Labour, and Welfare, highlighting the need for stronger cervical cancer control measures.
Read More
Fertility-sparing surgery matches standard surgery in cervical cancer survival
June 27th 2024A recent study reveals that fertility-sparing surgery offers similar survival outcomes to standard surgery for cervical cancer patients with tumors of 4 cm or smaller, potentially expanding treatment options for younger women.
Read More
HPV-16 identified as highest risk for CIN2 progression in women under active surveillance
June 24th 2024A recent study found that women with human papillomavirus -16 undergoing surveillance for cervical intraepithelial neoplasia grade 2 are at the highest risk of progression to more severe cervical lesions.
Read More